| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |